Cambridge Healthtech Institute’s 10th Annual

Clinical and Translational Biomarkers

Precision Medicine, Liquid Biopsy, and Clinical Trials

September 17-18, 2020


The promise of precision medicine has been driven by the need to accurately predict patient response to therapy while ensuring drug efficacy and safety. Reducing costs and the time required for drug development is also a driving force in the use of biomarkers. Cambridge Healthtech Institute’s 10th Annual Clinical and Translational Biomarkers meeting will cover novel biomarker discovery, clinical and analytical biomarker validation, and the role of biomarkers in clinical decision making.

Preliminary Agenda

PREDICTIVE BIOMARKERS FOR IMMUNO-ONCOLOGY

PD-L1 Immunohistochemistry (IHC) as a Predictive Marker for the PD-1/PD-L1 Axis Blockade

Mari Mino-Kenudson, MD, Professor, Pathology, Harvard Medical School

Proteome-Based Theranostics in Immuno-Oncology

Michael Roehrl, MD, PhD, Director, Precision Pathology Center, Memorial Sloan Kettering Cancer Center; Associate Professor, Pathology and Laboratory Medicine, Weill Cornell Medicine

IMMUNE PROFILING AND TUMOR MICROENVIRONMENT CHARACTERIZATION

Immune Profiling in an Evolving Immune Oncology Landscape

Darrell Borger, PhD, Associate Director, Translational Sciences, Head, Integrated Translational Technologies, Oncology Drug Development Unit, Takeda Pharmaceuticals

Molecular Signatures of Tumor Immune Evasion

Samir Hanash, MD, PhD, Director, McCombs Institute for Cancer Early Detection and Treatment, MD Anderson Cancer Center

Integrative Analyses of Environment, Microbiome, Immunity, and Tumor for Precision Oncology

Shuji Ogino, MD, MS, Professor, Pathology, Brigham & Women's Hospital, Harvard Medical School; Professor, Epidemiology, Harvard T.H. Chan School of Public Health; Chief of Molecular Pathological Epidemiology Program, Brigham & Women's Hospital; Associate Member, Broad Institute of MIT and Harvard

The Tumor Immune Microenvironment of Pre-Malignant Lesion in the Pancreas

Elizabeth Thompson, MD, PhD, Assistant Professor, Pathology and Oncology, The Johns Hopkins Hospital

ONCOLOGY BIOMARKERS ENABLING PRECISION MEDICINE

Precision Medicine Initiatives at the NCI

Tracy Lively, PhD, Chief, Diagnostics Evaluation Branch; Deputy Associate Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute

How to Catch Them All: Genomic Panels Big and Small

Jennifer Morrissette, PhD, Director, Clinical CytoGenomics Laboratory, Associate Professor, Pathology, University of Pennsylvania

BIOMARKER DISCOVERY AND TRANSLATION

Translational Biomarkers - From Discovery to the Clinic

Katherine Call, PhD, Senior Director, Head, Proteogenomics, Sanofi Translational Sciences

Maximizing the Return on Clinical Samples: Consideration for IO Discovery Biomarker Analysis

Amber Donahue, PhD, Senior Manager, Biomarker Clinical Assay Lead, Oncology Clinical Assay Group, Pfizer

Leveraging CyTOF Technology for Biomarker Discovery in a Clinical Setting

Emily Thrash, PhD, Scientist, Center for Immuno-Oncology Immune Assessment Laboratory, Dana-Farber Cancer Institute

BIOMARKERS FOR PATIENT SELECTION

Accelerating Oncology Drug Development by Patient Stratification

Hua Gong, MD, PhD, Senior Director, Head of Genomics Biomarker Development, Navigate Biopharma, a Novartis company

Predictive Molecular Marker for C. Difficile Infection Recurrence

Xuemei Zhao, PhD, Senior Principal Scientist, Merck

Utility of Biomarker Post-Translational Modifications Enabling Patient Stratification

Michael Baratta, BA/MCAHPM, Scientific Director and Chief of Staff, Clinical Biomarker Development Innovation, Takeda

LIQUID BIOPSY IN PRECISION MEDICINE

Liquid Biopsies Enabling Precision Medicine

Jonathan Beer, Director, FPM Lead of Disruptive Technologies, Novartis Precision Medicine

Liquid Biopsy for Brain Tumors

Brian Nahed, MD, MSc, Associate Professor, Neurosurgery, Harvard Medical School; Associate Director, Neurosurgery Residency Program, Massachusetts General Hospital


For more details on the conference, please contact:
Virginia Maxwell
Senior Associate Producer
Cambridge Healthech Institute
Phone: (+1) 781-972-5436
Email: vmaxwell@healthtech.com

For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286
Email: reymael@healthtech.com